← All indications
Chronic Limb-Threatening Ischemia
A severe form of peripheral artery disease in which a hypoperfusion of the BLOOD through an organ or tissue is caused by occlusion of peripheral arterial vessels. It is associated with the presence of chronic ischemic rest pain, ulceration or GANGRENE.
Drugs by status
Approved for this indication (1)
Phase 4 trials (12)
Phase 3 trials (17)
Phase 2 trials (30)
- plerixafor
- clbs12
- bone marrow derived mesenchymal stem cells
- Filgrastim
- jvrs-100
- platelet-rich plasma
- pegylated carboxyhemoglobin
- ticagrelor
- hyaluronic acid
- vepoloxamer
- autologous angiogenic cell precursors
- angiogenic cell precursors
- autologous cd34+ cells
- endothelial progenitor cells
- umbilical cord mesenchymal stem cells
- autologous stromal vascular fraction
- multigeneangio
- amg0001
- autologous mononuclear stem cell
- vm202
- autologous mesenchymal stem cells
- rivaroxaban
- allogeneic blood cells
- peripheral blood mesenchymal stem cells
- sodium chloride
- dexamethasone
- hydroxyethyl starch
- autologous adipose-derived mesenchymal stem cells
- yq23
- allogeneic mesenchymal stem cells
Phase 1 trials (7)